Department of Pharmaceutical Outcomes and Policy, University of Florida, 1225 Center Drive HPNP #3334, Gainesville, FL 32610, USA.
Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes and Policy, University of Florida, 1225 Center Drive HPNP #3334, Gainesville, FL 32610, USA.
J Infect Public Health. 2020 Jan;13(1):101-103. doi: 10.1016/j.jiph.2019.06.010. Epub 2019 Jul 3.
Pneumococcal vaccination rates remain sub-optimal in high-risk adult populations. This analysis quantified "missed opportunities," defined as number of healthcare encounters in unvaccinated patients who are recommended to be vaccinated. The 2015 National Health Interview Survey was used to assess vaccination status from adults 18-64 with risk factor and adults ≥65 years-old. In older adults, there was a mean of 5.15 (95% CI: 4.90-5.39) healthcare visits that could be opportunities for pneumococcal vaccination. In adults 18-64 years at high risk, there was a mean of 4.83 (95% CI: 4.66-4.99). Healthcare providers should take advantage of patient interactions to increase vaccination rates.
肺炎球菌疫苗接种率在高危成年人群中仍然不理想。本分析量化了“错失的机会”,定义为建议接种疫苗但未接种疫苗的患者的医疗保健次数。使用 2015 年全国健康访谈调查评估了有危险因素的 18-64 岁成年人和≥65 岁成年人的疫苗接种状况。在老年患者中,平均有 5.15 次(95%CI:4.90-5.39)医疗保健机会可用于肺炎球菌疫苗接种。在高危的 18-64 岁成年人中,平均有 4.83 次(95%CI:4.66-4.99)。医疗保健提供者应利用患者互动机会提高疫苗接种率。